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Ozer Ozcan1†, Arzu Uyar2†, Pemra Doruker2 and Ebru Demet Akten3*Abstract
Background: To understand the effect of the long intracellular loop 3 (ICL3) on the intrinsic dynamics of human
β2-adrenergic receptor, molecular dynamics (MD) simulations were performed on two different models, both of
which were based on the inactive crystal structure in complex with carazolol (after removal of carazolol and
T4-lysozyme). In the so-called loop model, the ICL3 region that is missing in available crystal structures was modeled
as an unstructured loop of 32-residues length, whereas in the clipped model, the two open ends were covalently
bonded to each other. The latter model without ICL3 was taken as a reference, which has also been commonly
used in recent computational studies. Each model was embedded into POPC bilayer membrane with explicit water
and subjected to a 1 μs molecular dynamics (MD) simulation at 310 K.
Results: After around 600 ns, the loop model started a transition to a “very inactive” conformation, which is
characterized by a further movement of the intracellular half of transmembrane helix 6 (TM6) towards the receptor
core, and a close packing of ICL3 underneath the membrane completely blocking the G-protein’s binding site.
Concurrently, the binding site at the extracellular part of the receptor expanded slightly with the Ser207-Asp113
distance increasing to 18 Å from 11 Å, which was further elaborated by docking studies.
Conclusions: The essential dynamics analysis indicated a strong coupling between the extracellular and
intracellular parts of the intact receptor, implicating a functional relevance for allosteric regulation. In contrast, no
such transition to the “very inactive” state, nor any structural correlation, was observed in the clipped model without
ICL3. Furthermore, elastic network analysis using different conformers for the loop model indicated a consistent
picture on the specific ICL3 conformational change being driven by global modes.
Keywords: ICL3, Molecular dynamics simulation, Transmembrane helix 6, G-protein binding site, Ligand docking,
Essential dynamicsBackground
As the largest family of membrane proteins in the human
genome, the G protein coupled receptors (GPCRs) are
structurally characterized by the presence of seven
membrane-spanning α-helical segments with an extracel-
lular N terminus and an intracellular C terminus. Upon
binding to agonists, a series of conformational changes
propagate along transmembrane helices and reach the
intracellular part of the receptor, which directly interacts
with the hetero-trimeric G-protein. Consequently, G pro-
tein’s activation triggers different cascades of events* Correspondence: demet.akten@khas.edu.tr
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reproduction in any medium, provided the ordepending on the type of agonists bound to the receptor.
Therefore, as the initiation point to the flow of signals into
cells, GPCRs are associated with a plenty of diseases that
make members of this family significant pharmacological
targets.
The first solved X-ray crystal structure of GPCR belongs
to bovine rhodopsin [1,2], which is followed by the crystal
structure of human β2-adrenergic receptor (β2AR) in the
inactive state [3,4]. Since 2007, the cholesterol bound form
of β2AR (PDB:3D4S) [5], the structure of turkey β1-adren-
ergic receptor (PDB:2VT4) [6], the structure of a methyl-
ated β2AR (PDB:3KJ6) [7] and various forms of inactive
states of β2AR bound to antagonists such as ICI 118,551
and alprenolol (PDB:3NY8,3NY9,3NYA,3PDS) [8,9] have
been reported. Finally, the nanobody-stabilized active state
of β2AR in complex with G-protein, has been solved byLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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these static pictures of the receptor remain insufficient to
describe the dynamic character of the receptor, which gov-
erns the function. It is a well-established concept that pro-
teins have an intrinsic ability to sample an ensemble of
distinct conformations in order to perform certain func-
tions [12]. The ligand simply selects the optimal receptor
conformation for binding followed by an induced fit to
stabilize the final conformation. Many questions remain
on these multiple, ligand-specific conformational states of
β2AR with different levels of activity from fully active to
fully inactive, which induce distinct signaling pathways.
The ternary complex model proposed in 1980 by Lefko-
witz and his coworkers [13] describes an allosteric mech-
anism for receptor activation. The agonist molecule, when
bound to the extracellular part, simply promotes and sta-
bilizes the high affinity β2AR-G protein complex. Follow-
ing the laws of thermodynamics, binding of G-protein
increases the receptor’s affinity for agonist binding to the
same extent. Fluorescence spectroscopic studies of β2AR
by Ghanouni et al. [14] presented a model with multiple,
agonist-specific receptor states, in which the activation oc-
curs through a sequence of conformational changes. They
also suggested that the activation barrier for transition
from intermediate to active state is high, and that in vivo
the barrier is more likely reduced by G protein binding.
The presence of an intermediate state is further supported
by the fluorescence spectroscopy studies of Swaminath
et al. [15,16], suggesting a mechanistic model for GPCR
activation, where agonist binding stabilizes a series of con-
formational states with distinct cellular functions.
In addition to experiments, several MD simulation stud-
ies have been conducted after the inactive and active states
of the receptor have been solved by X-ray crystallography.
One simulation study by Dror et al. [17] reveals that the re-
ceptor exists between two distinct inactive conformations
of the receptor, one with the ionic lock intact and one with
the lock broken. In 2011, Dror and his coworkers proposed
a completely different activation mechanism in which the
structural changes start at the G protein binding site propa-
gating upwards as opposed to agonist-induced conform-
ational changes that start at the agonist binding site and
propagate down to G protein binding site [18]. The
agonist-bound crystal structure of β2AR without a binding
partner (PDB:3PDS) recently revealed by Rosenbaum et al.
[9] is found to be identical to the inactive state of the recep-
tor (PDB:2RH1). This suggests that in the absence of a
G-protein, the receptor prefers to adopt the inactive con-
formation whether or not it is bound to an agonist. In other
words, the agonist molecule is not sufficient alone to shift
the equilibrium to the active state. Dror et al. [18] also pro-
posed an intermediate state for G-protein binding site,
which exists as a part of the receptor’s intrinsic dynamics.
Binding of a G-protein to this binding site simply promotesa transition to the active conformation, which is further sta-
bilized by an agonist bound at the extracellular region. The
most important feature about the dynamics of β2AR is the
strong coupling that exists between the intracellular G-
protein binding site and the extracellular ligand-binding site
of the receptor [7,19]. The receptor behaves like a pair of
pincers where the intracellular part becomes narrower as
the extracellular part becomes wider, and vice versa.
Due to its unstructured nature, ICL3 region is either un-
resolved in crystallographic experiments or completely re-
moved and replaced by T4-lysozyme (T4L) to facilitate the
crystallization. Thus, none of the experimental and simu-
lation studies have discussed the possible effect of ICL3 on
the intrinsic dynamics of the receptor. Its replacement by
T4L to facilitate crystallization did not prevent agonist-
induced conformational changes based on fluorescence
spectroscopy measurements [20]. Yet, it is well accepted
that its direct interaction with G-protein probably have a
significant role on the receptor’s dynamics and the activa-
tion/inactivation pathway [21,22].
In this study, the effect of ICL3 on receptor’s conform-
ational dynamics was investigated via two distinct models
of the receptor. Both models were generated from the in-
active state of the receptor (PDB:2RH1) after removal of
T4L. Moreover, the partial inverse-agonist carazolol was
removed from the binding site of both models, since the
goal of this work was to provide data about the intrinsic
dynamics of the receptor, i.e., the ensemble of conforma-
tions accessible to its apo form. According to the current
view on ligand binding, the equilibrium distribution of
conformational states may be shifted upon ligand binding.
In the so-called loop model, the ICL3 region was mod-
eled as an unstructured loop of 32-residues length and
inserted between two open ends of TM5 and TM6 (resi-
dues 230 and 263), whereas in the second model, these two
open ends were “clipped” or simply covalently attached to
each other. The “clipped” model of the receptor, serving as
a reference in our study, has been commonly used in recent
simulation studies as well [18,23]. Both models were sub-
jected to 1 μs MD simulation in a POPC membrane bilayer
at 310 K. The essential dynamics analysis was carried out to
reveal important allosteric coupling within the receptor in
the presence of ICL3. Two distinct snapshots taken from
the loop model’s trajectory were further used as docking
targets for an agonist and an antagonist molecule in order
to investigate the effect of ICL3 on binding site conforma-
tions. Finally, elastic network analysis was performed on
different conformations and loop models to reveal a con-
sistent picture on receptor intrinsic dynamics.
Results and discussion
Presence of ICL3 affects RMSDs and loop mobility
The difference between loop and clipped model dynam-
ics is illustrated in the root mean square deviation
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three different RMSD values are plotted for the loop
model after fitting all snapshots to the initial snap-
shot based on coordinates of either the whole protein
(red line: ALL Loop), the core region excluding ICL3
(green line: CORE Loop) or the transmembrane re-
gion composed of helices (blue line: TMEMB Loop). The
large RMSDs observed in loop model (ALL) are due to
the presence of ICL3. The core region of the loop model
is equivalent to the clipped model and thus, the com-
parison between their RMSD profiles (CORE Loop and
ALL Clipped) reveals that the clipped model has reached
a plateau at an earlier time (~200 ns) than the loop
model (~700 ns). The time at which the loop model’s
core region reaches the plateau corresponds to the time
when ICL3 stabilizes as well. The stabilization of ICL3
corresponds to a significant change in its conformation,
observed as close packing underneath the receptor,
which will be discussed later in the text.
On the other hand, the RMSD values of the trans-
membrane region (TMEMB) reach a plateau at around
50 ns in both models. This indicates that the structureFigure 1 RMSD profiles for the loop and clipped model simulations. (
CORE: without ICL3, TMEMB: transmembrane helices) of the receptor. (b) Rof transmembrane region is preserved comparably in
both models. Furthermore, the presence of ICL3 affects
the mobility of small intra- and extracellular loops
(ICL1, ICL2, ECL1, ECL2 and ECL3, see Figure 2
described in Methods) in the loop model, which are
present in the CORE profile but not the TMEMB. There
is a strong correlation between the RMSD profiles of the
whole protein and ICL3 (only), given by the uppermost
red and green lines in panels A and B, respectively. The
RMSD value of ICL3 is obtained after alignment of the
core region to the initial structure (RMSD-ICL3/FIT-
CORE; green line in Figure 1b). Thus, the extremely
high RMSD of whole receptor with ICL3 is a conse-
quence the high mobility of the long intracellular loop.
The root mean square fluctuation profiles (RMSF) are
plotted using the time range as [50 ns-1000 ns] for both
models (Figure 3). The RMSF of each alpha-carbon atom
in the protein is calculated based on the average struc-
ture of the aligned snapshots. The first 50 ns are ex-
cluded as the equilibration stage of the transmembrane
region in both models (see Figure 1a). The extent of the
average fluctuation during 950 ns is found to be highera) RMSDs plotted based on alignments using different regions (ALL,
MSD of ICL3 only (green line).
Figure 2 Two β2AR models used in MD simulations. (a) Loop
model with the missing ICL3 modelled using MODELLER, (b)
Clipped model without ICL3.
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model (blue line), in almost all protein regions, except
the ECL3 region. Another time range for the loop model
was taken as [700–1000 ns] (green line; LAST 300),
where the whole protein has reached a plateau (see
Figure 1b).
The most significant difference between two time
ranges for the loop model is in the mobility of the ICL3
region, which fell down to 2–3 Å in the second time
range from 16 Å (out of the range of Figure 3). In
addition, a relatively lower decrease in RMSF is observed
in all parts of the protein including the loops and the
more stable helices in the second time range. However,
such a difference cannot be observed in the mobility of
the clipped model based on the two time frames (not
shown). These results indicate that the fluctuation of
ICL3 region in the loop model is directly reflected on
every part of the protein structure, including the trans-
membrane regions. Once ICL3 becomes closely packed
under the receptor at around 700 ns (see next section),Figure 3 RMSF profiles of residues in the loop and clipped
models. Fluctuations are calculated using the whole 1 μs trajectory
(ALL) or the time frames of 0.7-1 μs (LAST 300). Presence of ICL3
imparts mobility to other loops of the receptor. Packing of ICL3
under the receptor hinders fluctuations after 700 ns.the mobility of the transmembrane region decreases
slightly and becomes more similar to that of the clipped
model.
Another important observation about the RMSF pro-
files in Figure 3 is the mobility of the ECL2 loop region,
which is at the extracellular side of the membrane and
plays an important role as an access point to the binding
site. For the loop model, during the last most stable
300 ns, the RMSF of ECL2 decreases to 5 Å from 6.5 Å,
as a consequence of the decrease in the mobility of
ICL3. But still, the mobility of ECL2 in the loop model is
higher than that in the clipped model irrespective of the
time ranges considered. The higher ECL2 mobility al-
lows a wider range of conformational sampling, which
would include the open/closed forms of the gateway to
the binding site, making the loop model’s binding site
more accessible and accommodating for diffusing li-
gands than the clipped model.
The conformational change of ICL3 gives rise to a “very
inactive” state of the receptor
Figure 4A shows the RMSD profiles of the sixth trans-
membrane helix (TM6) from its inactive (PDB:2RH1)
and its active states (PDB:3SN6) in reported crystal
structures. The RMSD is calculated for the intracellular
part of the helix composed of residues 267–282. In the
loop model (red), the deviation from both inactive and
active states starts to increase at around 600 ns and
levels off around 800 ns, amounting to a change of 2 Å.
On the other hand, no significant change is observed in
the clipped model (green). The deviation is illustrated in
Figure 4B, where the first snapshot of TM6 (blue) is
close to the inactive state (green) and the last snapshot
of TM6 (yellow) is found to be away from both the in-
active and the wide-open active state (magenta). The
second view of the receptor from the intracellular side
in Figure 4B shows that ICL3 becomes more wrapped
up under the core of the receptor (final frame shown),
which will be named as a “very inactive” state inaccess-
ible to G-protein binding.
This close packing of ICL3 is quantitatively repre-
sented in Figure 4C, which shows the sudden change in
the x-offset with respect to the y-offset. The value of x-
offset is the difference in the x coordinates between the
center of masses for the core of the receptor and the
ICL3 region. Similarly, the value of y-offset is calculated
from the difference in y coordinates of these center of
masses. Three distinct clusters are observed in time
ranges of [0–470] ns, [470–670] ns and [670–1000] ns.
The first (red) and third clusters (blue) correspond to
the open and packed states of ICL3, respectively. The
second one (green) represents a transition between the
two states. Interestingly, the second cluster’s starting
time at 470 ns corresponds approximately to the time at
Figure 4 Conformational change in the intracellular part of TM6. (A) RMSD profile of the TM6 intracellular part from its inactive and active
states in the loop (red) and clipped (green) models. (B) Initial (blue) and final (yellow) snapshots from 1 μs loop trajectory, showing TM5 and
TM6 in comparison with the inactive (green) and active (magenta) crystal structures. (C) Changes in the x-offset with respect to the y-offset
representing the change between center of masses of ICL3 and protein’s core.
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Additional file 1: Figure S1). It is an open question
whether these helical formations might trigger the tran-
sition to the packed state. Additionally, the onset of the
third cluster around 670 ns corresponds to the time, at
which TM6 starts to deviate from the reference crystal
structures (see Figure 4A).
The changes observed at the intracellular part of the
receptor seem to affect the extracellular part, specifically
the binding site of the receptor. Figure 5a illustrates the
profile of the distance between the pair of residues,
Ser207-OG on TM5 and Asp113-CG on TM3. Recent
simulation studies by Katritch et al. [24] have revealed
that tilting of TM5 towards the receptor axis enables an
optimum interaction between agonists and the two an-
chor sites, Asp113/Asn312 and Ser203/Ser204/Ser207
side chains. Based on experimental studies [25], the dis-
tance between the side chain oxygen of Ser207 and
gamma carbon of Asp113 should be within a range of
8 Å (blue, horizontal line) and 10 Å (purple line) in
order to accommodate the agonists at the binding site.
However, the distance profile in Figure 5a is most often
out of this critical range and even beyond the distancevalues of the inactive state, which is around 11 Å. At
around 600 ns, when the sudden conformational changes
in both TM6 and ICL3 occur, this distance starts to in-
crease from 13 Å to 16 Å in loop model (red). On the other
hand, there is no significant change in the distance profile
of the clipped model (green) after 600 ns as expected.
The variation in the distance between Ser207 and
Asp113 is illustrated in Figure 5b (top view, looking
down from the extracellular side), which shows two con-
formations of the receptor, with minimum and max-
imum distance values of 8.3 Å and 18.6 Å (shown as
light blue and purple, respectively). Clearly, the intracel-
lular part of TM5 is slightly moving into the core region
(see Figure 5b), while its extracellular part is moving
away from the core region of the receptor. As a result,
Ser207, which is located at the extracellular part of
TM5, drifts away from Asp113 on TM3, position of
which does not change notably. Similar motions are ob-
served for TM4 and TM6 as well. As a result, the en-
larged binding site becomes unfavorable for agonist
binding due to lack of some key interactions.
Figure 5c illustrates the correlation between the TM6
shift at the intracellular part of the receptor and the
Figure 5 Conformational change in the binding site. (a) Ser207(Oγ)-Asp113(Cγ) distance profiles for the loop (red) and clipped (green)
models. Blue and purple lines bracket the experimentally determined critical range in active states [25]. (b) Conformations representing the open
and closed forms of the binding site in loop model. (c, d) The correlations between TM6 shift and Ser207-Asp113 distance for the loop and
clipped models, respectively.
Figure 6 Ser203(Oγ)-Asp113(Cγ) distance profiles. The initial
distance indicative of a relatively open binding site decreases in all
simulations (1 μs and three 100 ns independent trajectories)
resulting from the positioning of TM6 and ICL3.
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receptor. In the loop model, the change in the RMSD
value of TM6 with respect to the active state happens at
around the same time as the increase in the Ser207-
Asp113 distance, whereas in the clipped model, no such
correlation is observed (see Figure 5d). Three different
states of the structure are observed in the loop model at
around [0–640], [640–770] and [770–1000] ns intervals.
In contrast, the conformational variations of the clipped
model remain in a restricted area, which corresponds to
the first conformational state ([0–660] ns) of the loop
model.
In addition to the 1 μs MD simulation, three inde-
pendent 100 ns MD simulations with different initial
conformations and velocities were performed as ex-
plained in Methods. Due to restrained conditions during
the preparation stage prior to MD runs, the Ser203-
Asp113 distance value was extended to ~16 Å from the
initial value of ~11-12 Å. Ser203 is another key residue
for binding that lies on the next turn above Ser207 on
TM5. The change in the distance between Ser203 and
Asp113 is mainly the result of a change in the positionof Ser203 (both backbone displacement and side chain
rotation). Within the first 20 ns of all four MD simula-
tions (including the 1μs simulation), the distance rapidly
decreases back to its initial value of ~11-12 Å as shown
in Figure 6. The explanation for such a decrease is that
all four simulations started with an expanded extracellu-
lar (binding site region) part and an intracellular part
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be in equilibrium when its extracellular part is open
(wide) and its intracellular part is closed (narrow) with
ICL3 closely packed underneath or vice versa. This is
the direct consequence of the strong allosteric coupling
that exists between extracellular and intracellular regions
of the receptor and this seems to be consistent with the
ternary complex model suggested by de Lean et al. [12].
The loop model shows a conformational variation in its
second intracellular loop (ICL2), which is correlated with
the motion of ICL3. Additional file 2: Figure S2 shows four
different stages of conformational variation of ICL2
changes with respect to intracellular part of TM6. Both
RMSD values are calculated with reference to the active
state (PDB:3SN6). However, no such major structural
change is observed in the clipped model. The motion of
ICL2 in the loop model is also illustrated, in which the
ICL2 between TM3 and TM4 steps aside as the ICL3
comes closer to the middle region (initial stage: blue, sec-
ond stage (at 700 ns): cyan, final stage: red, and active
crystal: green). No such conformational rearrangement in
ICL2 is observed in the clipped model. Additional file 3:
Figure S3 illustrates the change in the RMSD value of
ECL2 with the change in the Ser207-Asp113 distance. As
the distance increases in the loop model, there is a con-
formational variation in ECL2 with respect to the active
state. However, no such correlation is observed in the
clipped model. Clearly, the structural variation in ECL2 is
directly affected by the change in the distance as a result
of a shift of TM5 away from the binding site, which is in
turn a consequence of the ICL3 motion and TM6 shift at
the intracellular part of the receptor.
Ionic lock (Arg131-Glu268) is not a molecular switch
During 1 μs long MD simulation of the loop and clipped
models, which represent the inactive state of the recep-
tor, the ionic lock profiles are monitored as shown in
Additional file 4: Figure S4. Consistent with previous work
[18], the ionic lock seems to be on and off during the sim-
ulations of both models (in upper panels). Thus, this ionic
lock cannot distinguish between active and inactive states.
The cause behind the breakage/formation of this ionic
lock is found to be the result of a change in the rotational
state of the Χ angle of Glu268, which coordinates perfectly
well with the ionic distance profiles (in lower panels).
Furthermore, the increase in the distance between two
side chains that form the ionic lock, namely Arg131-N
and Glu268-O, coincides properly with the increase in the
distance between their alpha-carbons. In the profiles of
the inactive state, the backbone distance fluctuates at
around 9.5 Å and reaches 12.4 Å at most. However, in the
known crystal structure of the active receptor (PDB:3SN6),
the distance between alpha-carbons is around 16 Å as a
result of a significant outward shift in the intracellular partof TM6. Thus this backbone distance could be one pos-
sible measurement for detection of activation.
Essential dynamics analysis reveals the transition to the
“very inactive” state in the first principal mode
For both models, each frame in the trajectory was
aligned onto the initial structure. Then principal compo-
nent analysis (PCA) based on only Cα atom coordinates
was performed to understand the effect of ICL3 on the
essential dynamics of the receptor [26]. The first princi-
pal mode explains about 69% and 22% of the protein’s
overall motion in the loop and clipped models, respect-
ively. Figure 7a displays three different RMSD profiles
for the intracellular part of TM6 in the loop model after
alignment on the active state. These are computed for
the original trajectory (blue, same profile as in Figure 4A)
and for the two reconstructed trajectories, one including
only the first mode (red) and the other showing the cu-
mulative effect of the first five modes (green). Projection
of the MD trajectory onto the first principal eigenvector
(red) shows an abrupt change, which is coupled with the
transition to the “very inactive” conformation. The pro-
file obtained from the projection of cumulative five
modes, as expected, explains this transition better.
Additionally, the distance profiles between Ser207 and
Asp113 in the loop model was recalculated using Cα
atoms only as shown in Figure 7b. A high correspond-
ence between the original and the two reconstructed
profiles is observed as in Figure 7a. Also, a plot of
RMSD value versus the Ser207-Asp113 distance clearly
shows that the essential modes (first and cumulative
five) describe the distribution in the original trajectory
(Figure 7c). Thus, the closure of the ICL3 driven by the
first mode (Figure 7d) is strongly coupled with the
opening of the binding site indicated by the Ser207-
Asp113 distance. For the clipped model, same profiles are
plotted in Additional file 5: Figure S5. The profiles ob-
tained from the projection of the first and cumulative five
modes do not explain satisfactorily the dynamics of the
extracellular and intracellular regions of the receptor.
Elastic network modeling reveals coupling between
global modes and ICL3 conformational transition
MD simulations were performed on a receptor model
including a specific unstructured conformation of ICL3
obtained from MODELLER. In order to show the inde-
pendence of the observed phenomena from the initial
MD structure, ANM was performed on four distinct
conformations of the loop model. These were selected as
the initial, average and final structures of the 1 μs-long
loop trajectory, and a receptor model containing an al-
ternative unstructured conformation of ICL3, also pro-
vided by MODELLER. The RMSD between the
alternative loop model and the one used in our MD
Figure 7 Essential dynamics of the loop model. (a) RMSD profiles for the intracellular part of TM6 in the loop model’s original trajectory and
after the projection onto the first and the cumulative five principal modes. (b) Original and reconstructed profiles for the distance between
Ser207(Cα) and Asp113(Cα). (c) The correlation plot between RMSD of TM6 and Ser207-Asp113 distance. (d) Projection of the loop model’s
trajectory onto the first principal mode, shown as harmonic motion.
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alignment of transmembrane regions.
The correlation between PCA and ANM modes is














where pi and uj represent the i
th and jth normalized ei-
genvectors from PCA and ANM, respectively. Thesquared inner dot products are generally summed over the
first k =10 modes, which describe the collective subspaces of
each method. The average overlap values are 0.64, 0.72, 0.62
and 0.66 between the first 10 modes of PCA and ANM per-
formed with the initial, average and final structures of MD
run and the alternative loop model, respectively. These
values are quite high (relatively closer to 1), representing sat-
isfactory overlap between ANM and PCA subspaces.
In Figure 8, the conformational changes of ICL3 and
TM6 are shown for specific ANM modes that yield a
Figure 8 Collective modes driving ICL3 and TM6 towards the core of the receptor. (A) The first anharmonic principal mode for the 1 μs
MD trajectory (same red and blue conformers as in 7D, cyan representing the average MD structure), (B) the second slowest mode from ANM
performed on the average structure, and (C) the first mode from ANM performed on the alternative loop model. On the left panels, alternative
conformations (red and dark blue) are provided together with the average structure (cyan) for the specific mode. The right panels provide vector
representations of the same deformations based on average structures (intracellular view).
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component of MD run. The left and right panels on the
figure indicate different views (side and intracellular) for
each mode. Specifically, vector representations of deforma-
tions, shown from the intracellular part (right panels), indi-
cate clearly the inward movement of ICL3 and TM6 in the
1st mode of MD (Figure 8A), ANM 2nd mode for the aver-
age structure (O1,2 = 0.81, Figure 8B) and ANM 1st mode
for the alternative loop model (O1,1 = 0.57, Figure 8C).
The overlap matrices calculated based on residue
displacements of ICL3 and TM6 region only (see
Additional file 6: Figure S6) indicate several ANM modes
exhibiting high overlap with the first mode of MD. Thus,
slow modes of ANM clearly drive the significant con-
formational change of ICL3 and TM6 towards the recep-
tor core, independent of the ICL3 conformation/model
used. In summary, our ANM analysis justifies that the
ICL3 dynamics observed in MD run can be attributed to
be a feature of intrinsic receptor dynamics in conformity
with a recent study carried on catalytic loop motions for
different enzymes [27].
The clustering of MD snapshots reveals more
conformational variations in the loop model
The snapshots taken from the simulations of the loop
and clipped models are clustered all together based onFigure 9 Clustering profiles of all trajectories based on different regio
site, (c) ICL2 and (d) ECL2. All graphical representations were prepared usindifferent regions of the receptor: transmembrane region,
intracellular part of the receptor, ICL2 and ECL2 loop re-
gions using an RMSD cutoff of 1.8 Å, 1.8 Å, 3.7 Å and
3.3 Å, respectively. The region for the alignment is chosen
as the transmembrane region in all four cases. In all cluster
profiles shown in Figure 9, the simulation time is divided
into five ranges. Frames 1–5000, 5001–10000 and 10001–
11500 are taken from the μs-long loop run, μs-long clipped
run and the three short runs for the loop model.
The clustering profile of the transmembrane region
shows four distinct clusters for 1 μs simulation of the loop
model as illustrated in Figure 9a. Two of those clusters
dominate over the other two, since they contain 54% and
37% of the total snapshots, which are observed at around
[0–600] ns and [600–1000] ns, respectively. On the other
hand, two distinct clusters are obtained for the clipped
model, and only one of them dominates for 92% of the
time. For each of the three short MD simulations, there is
only one single cluster that dominates during 100 ns.
These results indicate that the transmembrane region of
the loop model alternates between two distinct conforma-
tions, while the clipped model’s transmembrane region
prefers to adopt only one. Interestingly, the second con-
formation in the loop model observed between 600 and
1000 ns coincides with the time at which the ICL3
changes its conformation and the receptor adopts a “veryns of the receptor. (a) transmembrane region, (b) G-protein binding
g MATLAB [28] in this article.
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similar clustering profile is obtained for the binding site
region as shown in Additional file 7: Figure S7. This is an
expected outcome considering that the binding site is em-
bedded in the transmembrane region.
Figure 9b shows the cluster profile of the intracellular
part of the receptor, which consists of residues interacting
with the G-protein based on the active crystal structure
(PDB:3SN6) [29]. Clearly, the loop model’s intracellular
part samples three distinct states while the clipped model’s
intracellular part only samples one conformation. In the
three short simulations, there is also one single conform-
ation dominating the others. The structural flexibility of
the intracellular part is critical in making contact with the
G protein. For the loop model, three snapshots were se-
lected from each cluster shown in Figure 9b as representa-
tives and illustrated in Additional file 8: Figure S8 with a
bottom view to show the contact of the receptor with the
helical segment of gamma subunit of G protein. In the ac-
tive crystal structure (PDB:3SN6) taken as a reference and
placed on top of the figure, G protein’s helical segment
nicely fits the binding cavity. At the initial stages of the
simulation, the binding cavity is almost preserved. Towards
the end of the simulation, the motion of ICL3 closes down
the G-protein binding site almost completely, as shown in
the last frame leaving no contact point for the G protein.
The clustering profile in Figure 9c, shows two dominant
clusters for the ICL2 region in both model. The two dis-
tinct states in the loop model are sampled for about 29%
and 58% of the time, while in the clipped model two major
clusters are sampled for 39% and 59% of the time. Each of
the short simulations of the loop model still does not show
structural variation during 100 ns, similar to other two
cases above. These results indicate that ICL3 has no sig-
nificant effect on the conformational sampling of ICL2.
Finally, the cluster profile in Figure 9d shows four dis-
tinct clusters for ECL2 region of the loop model, with
each consisting of a considerable amount of snapshots
and sampled consecutively during the simulation. On
the other hand, the clipped model’s one μs simulation as
well as three short simulations of the loop model, impart
no conformational variation to the ECL2 region. The
ECL2 loop region is the second extracellular loop cover-
ing the top of the receptor and plays a critical role of
providing a passage to the binding site region. Therefore,
the ability of ECL2 to sample various conformations, be-
ing a functionally important feature for the receptor, is
clearly enhanced in the presence of ICL3.
Docking results of epinephrine and ICI to an open and a
closed form of the binding site
Two frames of the loop model are selected from the 1
μs trajectory to represent the two extreme cases of
Ser207-Asp113 distance value (see Figure 5a, b). One ofthe conformers is a closed form with a distance value of
8.31 Å, which is in the range of active states (8–10 Å)
[26], while the other conformer represents an open form
with the maximum distance value of 18.63 Å. The
docked ligands are a natural agonist epinephrine, and
ICI, which is an antagonist with a known crystal con-
formation (PDB:3NY8). The epinephrine is chosen due
to its relatively small size, and ICI is selected because it
is a large antagonist with an experimentally determined
conformation.
Figure 10a illustrates the poses of epinephrine with
highest scores docked to open and closed forms of the
receptor (a top view looking down from the extracellular
region). Epinephrine is shown as sticks while the key
residues are in ball-and-sticks representation. The epi-
nephrine’s highest score conformation docked to closed
form (light blue) has more favorable interactions with
neighboring residues than the highest score conform-
ation docked to open form (magenta) of the receptor
(see Figure 10b for an alternative side view to the struc-
tures). There exist a total of eight neighboring residues,
which interact with epinephrine in closed form within a
radius of 3.5 Å, namely Asp113, Val114, Ala200, Ser204,
Ser207, Phe289, Phe290, and Asn293. Seven of them, ex-
cluding Ala 200, are known to be key interacting resi-
dues in agonist binding [30] (Additional file 9: see Figure
S9A, B showing interactions of epinephrine obtained
from MOE tool) [31]. On the other hand, the best pose
of epinephrine in the open form is found slightly out of
the binding site region making interactions with ten resi-
dues with a distance of less than 3.5 Å (Asp113, Val117,
Phe282, Cys285, Trp286, Phe289, Leu311, Asn312,
Gly315, Asn318), among which only three (Asp113,
Phe289 and Asn312) are key residues (see Figure 10a).
The other seven are not reported as being significant in
agonist binding. Considering the small size of epineph-
rine, the closed form is found to be more favorable than
the open form.
The docking results of ICI indicate a complimentary
situation. Due to its large size, the antagonist ICI cannot
fit into a narrow binding site in the closed form, but it can
be favorably docked into a wider binding site, such as the
open form. Figure 10C shows the highest score conforma-
tions docked in the open (magenta) and closed (light blue)
form of the receptor (see Figure 10d for a comparison to
the bound state of ICI in the crystal structure shown as
black sticks). The RMSD values of docked ICI to open
and closed forms with respect to its native state are deter-
mined as 3.95 Å and 8.16 Å, respectively. Clearly, ICI
when bound into a wider binding site is able to interact
with experimentally reported key residues for antagonist
binding. ICI interacts with eight residues within a radius
of 3.5 Å, Asp113, Tyr199, Ser203, Ser204, Phe208, Trp286,
Tyr308 and Asn312, of which five (Asp113, Ser203,
Figure 10 Best docked poses of ligands. (a, b) for agonist epinephrine and (c, d) for antagonist ICI in open (magenta) and closed (light blue)
forms of the receptor, showing both top and side views. Ligands are shown in sticks representation in the same color with its docked structure.
Key residues interacting with the ligand are labeled and also shown as ball-and-stick. For comparison, the bound state of ICI in the crystal
structure (PDB:3NY8) is shown in black. All molecular graphics were prepared using PyMOL [32] and VMD [33] in this article.
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(see Additional file 9: Figure S9 for the specific interac-
tions of ICI). Furthermore, ICI is correctly oriented in the
binding pocket with the hydrophobic catechol ring inter-
acting with Ser203 and Ser204, and its polar end interact-
ing with Asp113. However, in the closed form, ICI is
improperly positioned in the binding pocket, interacting
within a radius of 3.5 Å with Thr110, Asp113, Val114,
Phe193, Tyr199, Phe289, Asn293, Lys305 and Tyr308 of
which only two (Asp113 and Val114) are known key
residues.
To sum up, the agonist is favorably bound to the
closed form, which coincides with the ICL3-open con-
formation during the first half of the simulation. The
ICL3-open conformation may correspond to an inter-
mediate state that promotes G-protein binding, which
seems to be stabilized by the presence of the agonist at
the binding site. An MD simulation, where the binding
site would be constrained to the agonist boundgeometry, would give more insight in this perspective. In
the second half of the simulation, the open geometry of
the binding site is observed to which the antagonist fa-
vorably docks. This “very inactive” state corresponds to
the closely packed ICL3 that completely blocks the G-
protein binding site.
Conclusions
The crystal structure of β2AR has been resolved for the
first time in 2007, and since then in silico studies have
been conducted to unravel structure-dynamics-function
relationship of this G-protein coupled receptor. How-
ever, the missing intracellular loop ICL3, which is known
to interact with the G protein at the cytoplasmic side,
has not been considered or elaborated so far in these
studies. In this respect, our MD study exposed the
marked effect of ICL3 on collective dynamics and justi-
fied the correlated motion between the intracellular G-
protein binding site and the extracellular ligand-binding
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of pincers where the intracellular part becomes narrower
as the extracellular part becomes wider, and vice versa.
In accordance with this coupling behavior, our μs long
MD simulation of β2AR, which included the modeled
intracellular loop ICL3, revealed a so-called “very in-
active” state of the receptor, which has not been reported
before. In the second half of the simulation, the ICL3
moved toward the core of the receptor and completely
blocked the G-protein binding site. Consequently, the
intracellular part of TM6, adjacent to ICL3, also shifted
toward the core of the receptor. This conformational
change in TM6 is in the opposite direction with respect
to experimentally observed deformation during activa-
tion [9], which is observed as an expansion or outward
movement towards the lipid membrane. This new in-
active state of the receptor may provide insight into the
design of novel therapeutic drugs.
Another important observation is the correlated mo-
tion between the binding site and the G-protein binding
site regions. At around the same time when the ICL3
blocked the G-protein binding site, the extracellular
binding site of the receptor expanded. The expansion
was detected based on the distance profile between two
anchor residues, Ser207 and Asp113, critical for agonist
binding. In line with these findings, our docking studies
indicated favorable antagonist binding to the expanded
binding site (closed ICL3) and agonist binding to the
closed binding site (open ICL3).
This coupled conformational change seems to be trans-
mitted from the intracellular part to the extracellular part
of the receptor via TM5 and TM6. As Sara Linse stated in
her review [34], “a 7TM receptor is like a bundle of rods
immersed in the membrane and if a ligand grips the bun-
dle at one end, the bundle opens up like a bouquet of roses
at the other end”. In our study, the intracellular end is
gripped or held tight by ICL3, and consequently the extra-
cellular part opened up. In other words, ICL3 played the
dominant role in inducing the change in the intracellular
part, which induced in turn the extracellular part. This
dominancy of ICL3 is expected due to its high mobility,
which is also a desirable quality for initiation of interac-
tions with intracellular proteins [20,21]. Thus, we suggest
that when left without ICL3, the receptor would not be
able to sample that inactive state at all.
This transition to the “very inactive” state took place
within a time frame of about 0.1 μs (starting at ~ 0.6 μs).
In the last 0.3 μs of the simulation, ICL3, which was ob-
served to be the most mobile region of the receptor dur-
ing the whole simulation, preserved its close state.
Principal component analysis of 1 μs long MD trajectory
showed that the first principal mode, which explains
69% of the overall motion governs the transition from
the initial inactive state to the “very inactive” state.At this point it may be argued that our simulation
conditions, such as the absence of any ligand at the
binding site and/or intracellular proteins that may inter-
act with ICL3, depict a non-physiological environment.
Even though, the receptor function is clearly linked with
its interacting partners, our aim was to elucidate the in-
trinsic conformational dynamics of the intact receptor.
Based on the widely accepted population shift mechan-
ism [35-37], we tried to uncover the pre-existing con-
formational states of the apo receptor, which may be
shifted and/or modified by the presence of binding part-
ner(s). In fact, our ANM analysis using different con-
formers/models of ICL3 strengthened our MD results
on receptor dynamics. Either the first or second collect-
ive mode in ANM was found to be coupled with the
specific motion of ICL3, independent of the model used.
In contrast, none of these conformational transitions,
nor any allosteric coupling between intra- and extracel-
lular parts, were observed in the clipped model simula-
tion lacking ICL3 region. Thus, we stress that the
presence of ICL3 provides a more realistic constriction
than those of clipped and non-clipped (loose ends)
models so far used in β2AR simulations.
Future works will be focusing on the loop model,
which will consist of constraining the binding site region
to observe the reverse transition (or release) from the
“very inactive” state to the inactive/intermediate state
and possibly the active state with an opening of the G-
protein binding site.
Methods
Preparation of the receptor models
The X-ray crystallographic structure of human β2AR in
complex with T4 lysozyme (T4L) (PDB:2RH1) at 2.40 Å
resolution [3] was used as the initial conformation. After re-
moval of T4L, the missing intracellular loop region (ICL3)
between residues 231 and 262 was modeled as an unstruc-
tured loop of 32-residues length via MODELLER [38]. Even
though ICL3 possibly exists as an unstructured loop [33],
our modeled loop in Figure 2a interestingly resembles a
conformer generated from a fully extended chain by Dror
et al. [18]. Moreover, it is expected that ICL3 can sample
various conformations during our 1 μs long run.
In the second model, Leu230 and Lys263, which are
the two ends of the missing region, were covalently at-
tached to each other via a peptide bond to form the
“clipped” model (Figure 2b), which has been commonly
used in simulation studies.
Preparation of the environment with the receptor
Each model was later embedded into a palmitoyloleoyl-
phosphatidylcholine (POPC) membrane bilayer along
the z-axis using VMD’s Membrane Plug-in Tool, v1.1
[39]. The receptor was positioned with an oblique angle
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membrane and the z-axis [40]. A total of fifteen internal
water molecules detected experimentally in the crystal
structure were retained because they make hydrogen
bonds with the most conserved residues of the receptor
and thus possibly contribute to its structural stability.
Using VMD’s solvate module, the protein-lipid system was
solvated in both intracellular and extracellular sides with a
thickness of 15 Å and 13 Å for the “loop” and “clipped”
model, respectively. Finally, the protein-lipid-water system
was ionized with Na+ and Cl- ions to make the total
charge of the system to be equal to zero, which is ne-
cessary for Particle-Mesh Ewald summation method used
in electrostatic energy calculations. The resulting perio-
dic box dimensions were (86×86×100) and (77×69×90)
in Angstrom for the “loop” and “clipped” models,
respectively.
Molecular dynamics simulations
Using the suggested procedure for membrane protein sys-
tem preparation [41], both models were subjected to three
preparation stages. The system consisted of three compo-
nents of different types, each having a different response
time to outside forces. Thus, to reach the equilibrium fast,
it was practical to keep some components fixed, while
other components were free to move. The first equilib-
rium stage consisted of melting the lipid tails where only
the lipids were free to relax while the protein and waters
were held fixed. At the end of the simulation, the unrealis-
tically aligned lipid molecules, transformed into a more
disordered, liquid-like structure. In the second preparation
step, the protein’s motion was constrained while lipid and
water molecules were free to move. Finally in the third
stage, the protein was released, and all components were
allowed to relax. In every preparation stage, the system
was subjected to 1000 steps of energy minimization
followed by 0.5 ns MD simulation. At the end of the third
stage, the area per lipid was stabilized at 0.635 nm2/lipid
in agreement with the experimentally measured value of
0.65 nm2/lipid [42]. Also, the surface area of the mem-
brane in -xy directions decreased due to close packing of
lipid molecules with the protein.
Each model was later subjected to 1 μs MD simulation
with NAMD v2.7 software tool [41]. CHARMM22
[43,44] and CHARMM27 [45,46] forcefields were used
to describe the interaction potential of the protein and
the lipid respectively, and waters were treated explicitly
using TIP3P model [47]. The system was composed of a
total of 68,001 and 42,701 atoms for the “loop” and
“clipped” model, respectively. MD simulation was per-
formed at constant NPT at 310 K using Langevin dy-
namics for all non-hydrogen atoms, with a Langevin
damping coefficient of 5 ps-1. The system was kept at a
constant pressure of 1 atm by using a Nose–HooverLangevin piston [48] with a period of 100 fs and damp-
ing timescale of 50 ps. Long-range electrostatic interac-
tions were treated by particle mesh Ewald (PME)
method, with a grid point density of over 1 Å. A cutoff
of 12 Å was used for van der Waals and short-range
electrostatics interactions with a switching function.
Time step was set to 2 fs by using SHAKE algorithm for
bonds involving hydrogens [49] and the data was re-
corded at every 200 ps. The number of time steps be-
tween each full electrostatics evaluation was set to 2.
Short-range non-bonded interactions were calculated at
every time step.
For the “loop model”, three additional 100 ns long MD
simulations starting with different initial velocities were
performed alongside 1 μs MD simulation. The aim was
to possibly explore different conformational subspaces
than those visited during the long trajectory of the loop
model.
Docking calculations
Docking was performed using the software tool AutoDock
v4.0 [50]. The docking site was selected based on the loca-
tion of the partial inverse agonist carazolol in the complex
structure (PDB:2RH1). Two distinct snapshots taken from
MD trajectory were used as target structures. Lamarckian
genetic algorithm was used to explore the conformational
space. A total of 100 runs were performed for each struc-
ture with each run consisting of 1.0×106 and 1.5×106
energy evaluations for epinephrine and ICI ligands, re-
spectively. Grid box constructed with a spacing of 0.375 Å
had dimensions of 24 Å × 24 Å × 24 Å for all dockings.
For each docking experiment, the pose with the highest
score (lowest binding energy of AutoDock) was used as
the most probable solution for that complex.
Elastic network analysis
The collective/global modes of the protein were extracted
via the anisotropic network model (ANM) [51,52], which
describes the protein as a coarse-grained elastic network
of harmonic springs based on a minimum-energy folded
conformation. The network is formed simply, by conn-
ecting the close-neighboring alpha-carbon atom (called
nodes) pairs in the folded structure. The slow or the low-
frequency modes extracted from normal mode analysis of
the elastic network are known to successfully describe the
functional conformational changes.
In our current work, the receptor’s loop model was
embedded into a coarse-grained membrane environment
according to the methodology provided in Lezon et al.
[53] The membrane consisting of spheres arranged in an
FCC lattice had a diameter of 80 Å and a thickness of
33 Å. The cutoff value for pairwise interactions between
nodes was taken as 11 Å. The force constants of har-
monic springs were selected as 1.0, 2.0 and 4.0 for
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membrane type of pairwise interactions, respectively. In
this model, the membrane environment serves as a con-
striction and thereby inhibits the unrealistically large
fluctuations of the transmembrane helices that would be
observed if ANM were applied to the protein alone [53].
Additional files
Additional file 1: Figure S1. Secondary structure profile in the loop
model. Small helical formations are observed in ICL3. (Color scale: 0 =
turn, 1 = coil, 2 = isolated bridge, 3 = beta sheet, 4 = alpha helix, 5 = 3–10
helices, 6 = Pi helix).
Additional file 2: Figure S2. Correlation between RMSD values of ICL2
and lower TM6. (a) loop, and (b) clipped model. (c) Snapshots showing
ICL2 in the loop model, shown from intracellular side.
Additional file 3: Figure S3. Correlation between RMSD value of ECL2
and Ser207(Oγ)-Asp113(Cγ) distance. (a) loop, and (b) clipped model.
Additional file 4: Figure S4. Ionic lock profiles. (a) loop and (b) clipped
model. The ionic lock is between guanidinium nitrogen of Arg131 and
carboxylate oxygen of Glu268. Profiles of Χ angle of Glu268 for the (c)
loop and (d) clipped models, respectively.
Additional file 5: Figure S5. Essential dynamics of the clipped model.
(a) RMSD profile for the lower part of TM6 in the clipped model’s original
trajectory (blue) and after the projection onto the first (red) and the
cumulative five (green) principal modes. (b) Original and reconstructed
profiles for the distance between Ser207(Cα) and Asp113(Cα). (c) The
correlation plot between RMSD of TM6 and Ser207-Asp113 distance. (d)
Projection of the clipped model’s trajectory onto the first principal mode,
shown as harmonic motion.
Additional file 6: Figure S6. The loop overlap matrices between the
first five modes of PCA (of 1 μs MD run) and the first 20 slowest modes
of ANM performed on (A) average structure of 1 μs MD run, (B)
alternative loop model from MODELLER, (C) initial and (D) final frames
from 1 μs MD run. The loop overlap is calculated as the correlation
cosine between the eigenvectors for the specific region including ICL3
and intracellular part of TM6.
Additional file 7: Figure S7. Clustering profile of all trajectories based
on the binding site region.
Additional file 8: Figure S8. Representative snapshots which are
closest to the average structure (centroid) of each three clusters in
Figure 8B for the loop model. (A) active crystal structure (PDB id: 3SN6),
snapshots taken at (B) 52.8 ns (cluster #3), (C) 524 ns (cluster #1) and (D)
806 ns (cluster #2). The gamma subunit of G protein is partly shown in
red. All ICL3 regions are colored in a darker tone.
Additional file 9: Figure S9. Ligand-receptor interactions. (A, B) for the
best poses of epinephrine, and (C, D) for the best poses of ICI in open
and closed forms, shown in Figure 9.
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